Product NDC: | 0310-0754 |
Proprietary Name: | CRESTOR |
Non Proprietary Name: | Rosuvastatin calcium |
Active Ingredient(s): | 40 mg/1 & nbsp; Rosuvastatin calcium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0310-0754 |
Labeler Name: | AstraZeneca Pharmaceuticals LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021366 |
Marketing Category: | NDA |
Start Marketing Date: | 20030818 |
Package NDC: | 0310-0754-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0754-30) |
NDC Code | 0310-0754-30 |
Proprietary Name | CRESTOR |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0754-30) |
Product NDC | 0310-0754 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Rosuvastatin calcium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20030818 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | ROSUVASTATIN CALCIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |